Knockdown of Cx43 using shRNA in a LN229 glioma cell line increases Bax expression, reduces co-localization of CytC with mitochondria, and conveys reduced TMZ resistance which increases tumor susceptibility to pharmaceutical treatment in vitro (Murphy et al., 2000, 2012). This evidence concerns the gene BAX and glioma.